• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Aksìa backs machinery manufacturer Vomm

  • Alessia Argentieri
  • Alessia Argentieri
  • 27 August 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Aksìa Group has acquired a majority stake in Italy-based industrial machinery specialist Vomm.

The deal is valued at around €30m, which equates to approximately 3x the company’s EBITDA, Unquote understands.

Aksia acquired a 65% stake, while the founding Vezzani family retained a minority via the holding company Ambiente & Nutrizione.

Vomm

  • DEAL:

    Buyout

  • VALUE:

    €30m

  • LOCATION:

    Rozzano

  • SECTOR:

    Industrial machinery

  • FOUNDED:

    1968

  • TURNOVER:

    €35m (2019)

  • EBITDA:

    €10m (2019)

  • STAFF:

    130

Following the deal, Corrado Vezzani will stay on with the business and continue to lead the company maintaining his role of president of the board.

Marco Rayneri, managing partner of Aksia, said: "We plan to consolidate the business both in the domestic and international markets, increase Vomm's production capacity and pursue a buy-and-build strategy with new add-on acquisitions."

This is the third deal made by Aksìa Capital V, following its investment in dental clinics business Primo Group, which was acquired by the GP from Archimed in October 2019; and its purchase of frozen pizza producer Valpizza, bought last month.

Aksìa V targets European businesses with potential for high growth and international expansion, generating EBITDA of €4-25m from revenues in the €20-120m range. It deploys equity tickets in the €15-25m bracket and applies moderate leverage of around 2.5-3x.

Company
Founded in 1968 and based in Rozzano, near Milan, Vomm manufactures machinery and industrial plants used for polluted soil decontamination, waste sterilisation and sanitisation, crystallisation of saturated liquids, pasteurisation, gluten deactivation and starch modification.

Its products and technologies, including its proprietary Turbo Technology, are used by the food, chemical and pharmaceutical industries.

Vomm generates annual EBITDA of around €10m from revenues of €35m in 2019. It employs 130 staff.

People
Aksìa Group
– Marco Rayneri (managing partner).
Vomm – Corrado Vezzani (president).

Advisers
Equity
– Giliberti Triscornia e Associati (legal); EY (financial due diligence); Russo De Rosa e associati (tax).
Company – Pedersoli Studio Legale (legal); K Finance (corporate finance); KPMG (financial due diligence); Studio Bertolli e associati (tax).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • Industrials
  • Aksia Group
  • Italy
  • EY (Ernst & Young)

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013